The use of Praziquantel MDA has been generally successful in eradicating bilharzia as a public health problem in children aged 5–14 years. Many biomedical and biological investigations on NTDs, particularly Bilharzia, have been conducted because its spectrum effect extends beyond child health to four other SDGs[1]. However, despite many successes, bilharzia …

---

View more Research Information